- Home
- RQI vs VIR Comparison
RQI vs VIR Comparison
Compare RQI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RQI
- VIR
- Stock Information
- Founded
- RQI 2002
- VIR 2016
- Country
- RQI United States
- VIR United States
- Employees
- RQI N/A
- VIR N/A
- Industry
- RQI Trusts Except Educational Religious and Charitable
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- RQI Finance
- VIR Health Care
- Exchange
- RQI Nasdaq
- VIR Nasdaq
- Market Cap
- RQI 1.7B
- VIR 1.4B
- IPO Year
- RQI N/A
- VIR 2019
- Fundamental
- Price
- RQI $12.48
- VIR $6.70
- Analyst Decision
- RQI
- VIR Buy
- Analyst Count
- RQI 0
- VIR 6
- Target Price
- RQI N/A
- VIR $35.67
- AVG Volume (30 Days)
- RQI 432.6K
- VIR 1.3M
- Earning Date
- RQI 01-01-0001
- VIR 05-01-2025
- Dividend Yield
- RQI 8.20%
- VIR N/A
- EPS Growth
- RQI N/A
- VIR N/A
- EPS
- RQI N/A
- VIR N/A
- Revenue
- RQI N/A
- VIR $74,205,000.00
- Revenue This Year
- RQI N/A
- VIR N/A
- Revenue Next Year
- RQI N/A
- VIR $17.69
- P/E Ratio
- RQI N/A
- VIR N/A
- Revenue Growth
- RQI N/A
- VIR N/A
- 52 Week Low
- RQI $9.17
- VIR $6.40
- 52 Week High
- RQI $12.64
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- RQI 44.31
- VIR 32.44
- Support Level
- RQI $12.29
- VIR $6.40
- Resistance Level
- RQI $12.64
- VIR $7.26
- Average True Range (ATR)
- RQI 0.23
- VIR 0.32
- MACD
- RQI -0.02
- VIR 0.02
- Stochastic Oscillator
- RQI 50.00
- VIR 28.44
About RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.